We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$93.4B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$104B
AUM Growth
+$12.8B
(+14%)
Cap. Flow
+$10.7B
Cap. Flow
% of AUM
10.27%
Top 10 Holdings %
Top 10 Hldgs %
37.32%
Holding
3,165
New
694
Increased
888
Reduced
890
Closed
626
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| 1 | Technology | 19.25% |
| 2 | Consumer Discretionary | 13.51% |
| 3 | Healthcare | 11.06% |
| 4 | Financials | 8.19% |
| 5 | Communication Services | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Vertex
VERX
$2.1B
| $600K | ﹤0.01% |
30,068
-38,400
| -56% | -$831K |
|
2002
Enbridge
ENB
$120B
| $592K | ﹤0.01% |
12,371
+8,088
| +189% | +$386K |
|
2003
La-Z-Boy
LZB
$1.55B
| $588K | ﹤0.01% |
15,785
-100,987
| -86% | -$3.54M |
|
2004
AC Immune
ACIU
$249M
| $586K | ﹤0.01% |
+186,709
| New | +$589K |
|
|
FFWM
2005
DELISTED
First Foundation Inc
FFWM
| $583K | ﹤0.01% |
94,562
+9,846
| +12% | +$55.1K |
|
|
NVX
2006
NOVONIX
NVX
$112M
| $582K | ﹤0.01% |
+575,816
| New | +$817K |
|
2007
PMV Pharmaceuticals
PMVP
$68.3M
| $581K | ﹤0.01% |
465,086
-147,540
| -24% | -$198K |
|
|
ODV
2008
Osisko Development Corp
ODV
$716M
| $581K | ﹤0.01% |
166,467
-647,065
| -80% | -$2.22M |
|
2009
Strawberry Fields REIT
STRW
$181M
| $577K | ﹤0.01% |
44,058
-7,851
| -15% | -$96.1K |
|
2010
Planet Fitness
PLNT
$4B
| $575K | ﹤0.01% |
5,300
-6,800
| -56% | -$700K |
|
2011
Dimensional US Targeted Value ETF
DFAT
$14.3B
| $575K | ﹤0.01% |
+9,653
| New | +$563K |
|
2012
J. Jill
JILL
$239M
| $573K | ﹤0.01% |
41,791
+4,346
| +12% | +$65.7K |
|
2013
Turning Point Brands
TPB
$1.57B
| $566K | ﹤0.01% |
5,222
-2,455
| -32% | -$240K |
|
2014
California Resources
CRC
$4.74B
| $566K | ﹤0.01% |
12,660
-601,134
| -98% | -$28.5M |
|
|
LENZ
2015
LENZ Therapeutics
LENZ
$164M
| $564K | ﹤0.01% |
+35,252
| New | +$1.03M |
|
2016
Betterware México
BWMX
$679M
| $564K | ﹤0.01% |
39,667
-31,749
| -44% | -$438K |
|
2017
NatWest
NWG
$69.6B
| $561K | ﹤0.01% |
+32,063
| New | +$508K |
|
|
CVSA
2018
Covista Inc
CVSA
$4.53B
| $561K | ﹤0.01% |
+5,419
| New | +$621K |
|
2019
Mesa Laboratories
MLAB
$525M
| $560K | ﹤0.01% |
7,137
-7,463
| -51% | -$568K |
|
2020
GE Aerospace
GE
$369B
| $560K | ﹤0.01% |
+1,818
| New | +$547K |
|
2021
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$310M
| $556K | ﹤0.01% |
+36,066
| New | +$556K |
|
2022
Full House Resorts
FLL
$93.6M
| $553K | ﹤0.01% |
211,982
-59,827
| -22% | -$161K |
|
2023
Customers Bancorp
CUBI
$2.58B
| $553K | ﹤0.01% |
7,566
-46,733
| -86% | -$3.21M |
|
2024
Goldman Sachs BDC
GSBD
$992M
| $553K | ﹤0.01% |
59,580
-378,074
| -86% | -$3.71M |
|
2025
TaskUs
TASK
$515M
| $552K | ﹤0.01% |
46,829
-18,704
| -29% | -$239K |
|
Similar funds
